Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Kringle Pharma

Explore full profile

Kringle Pharma is a late clinical-stage biopharmaceutical company focused on research and development of regenerative medicines

Toyonaka, JapanFounded 2001Biotech & Life Sciences
Valuation $10–25M Last recorded · 2026
Revenue <$1M Latest reported FY
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Kringle Pharma and the history behind them.

About Kringle Pharma

Kringle Pharma is a late clinical stage biopharmaceutical company dedicated to the research, development, and commercialization of innovative medicines for patients suffering from incurable diseases. The company primarily focuses on conditions such as Acute Spinal Cord Injury and Amyotrophic Lateral Sclerosis (ALS). Operating in the global healthcare market, Kringle Pharma serves patients, healthcare providers, and medical institutions. The business model revolves around developing proprietary drug candidates through rigorous clinical trials and subsequently licensing these drugs to pharmaceutical companies for commercialization. Revenue is generated through licensing agreements, milestone payments, and royalties from drug sales.

Source: Dealroom company data

At a glance

Founded
2001
Headquarters
Toyonaka, Japan
Sector
Biotech & Life Sciences

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Investors

26 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • Tohoku University Venture Partners

Series B and later25 investors entered at this stage

  • Nissay Capital
  • Ant Capital Partners
  • Zenyaku Kogyo
  • Nippon Venture Capital
  • DBJ Capital
  • Cyberdyne
  • ReproCELL
  • Keio Innovation Initiative
  • Toho Lease
  • Gogin Capital
  • Kanagawa Science Park
  • Toho Holdings (Japan)
  • M3
  • POC Clinical Research
  • AMG
  • Venture Labo Investment
  • HU Holdings
  • OKB Co
  • Osaka University Venture Capital
  • Yitu Capital
  • Chishima Real Estate
  • HT Capital
  • Resona Capital
  • Nanto Bank
  • Maruishi Pharmaceutical Co. Ltd.

Talent

Book a demo to see the people
Team profiled 2 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇯🇵 Japan · Toyonaka HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Kringle Pharma on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Kringle Pharma on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles